Stem cell therapy for chronic pain management

Review of uses, advances, and adverse effects

Krishnan Chakravarthy, Yian Chen, Cathy He, Paul Christo

Research output: Contribution to journalReview article

Abstract

Background: This review article outlines the recent advances, uses, and adverse effects of cell-based therapy for chronic pain management. Cell based therapies are gaining increasing ground as novel treatment modalities for a variety of pain pathologies that include, but are not limited to, neuropathic pain and degenerative disc disease. As these treatment modalities become more common practice, we have focused our review to provide pain practitioners and other practicing physicians an understanding of the technology and to summarize key clinical data and existing clinical trials that are being pursued by clinical investigators worldwide. Objective: Review of stem cell technology and applications in pain management. Study Design: Narrative review. Methods: The Pubmed NCBI and EMBASE databases was utilized to review published reports of clinical studies reported from 2000 to 2015, and ClinicalTrials.gov (www. clinicaltrials.gov/ct2/search) search function was used to document ongoing clinical trials [keywords: “chronic pain,” “disc pain,” “cell therapy,” “osteoarthritis,” “neuropathic,” “stem cell”] currently active and recruiting patients. Results: Articles were screened by title, abstract, and full article review. They were then analyzed by specific clinical indications and appropriate data were presented based on critical analysis of those articles. Limitations: More studies looking at the systematic use of stem cells in pain management will be required to draw conclusions about the benefits of the technology. Conclusion: Though the data from existing studies look promising for the use of stem cells as a novel therapeutic strategy for discogenic pain, neuropathic pain, and osteoarthritis, additional clinical studies will be needed to validate the benefit of the technology for clinical use. However, we hope that this narrative review will help guide pain physicians in making informed decisions for their patients about the potential of cell-based therapy for treating chronic pain conditions.

Original languageEnglish (US)
Pages (from-to)293-305
Number of pages13
JournalPain Physician
Volume20
Issue number4
StatePublished - May 1 2017

Fingerprint

Pain Management
Cell- and Tissue-Based Therapy
Chronic Pain
Stem Cells
Pain
Technology
Neuralgia
Osteoarthritis
Clinical Trials
Physicians
PubMed
Decision Making
Therapeutics
Research Personnel
Databases
Pathology
Clinical Studies

Keywords

  • Chronic pain
  • Clinical trials
  • Disc pain
  • Mesenchymal stem cells
  • Neuropathic pain
  • Osteoarthritis
  • Pain management
  • Stem cell therapy

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Stem cell therapy for chronic pain management : Review of uses, advances, and adverse effects. / Chakravarthy, Krishnan; Chen, Yian; He, Cathy; Christo, Paul.

In: Pain Physician, Vol. 20, No. 4, 01.05.2017, p. 293-305.

Research output: Contribution to journalReview article

@article{10209a58c0584393b79b76f1fb9de5a6,
title = "Stem cell therapy for chronic pain management: Review of uses, advances, and adverse effects",
abstract = "Background: This review article outlines the recent advances, uses, and adverse effects of cell-based therapy for chronic pain management. Cell based therapies are gaining increasing ground as novel treatment modalities for a variety of pain pathologies that include, but are not limited to, neuropathic pain and degenerative disc disease. As these treatment modalities become more common practice, we have focused our review to provide pain practitioners and other practicing physicians an understanding of the technology and to summarize key clinical data and existing clinical trials that are being pursued by clinical investigators worldwide. Objective: Review of stem cell technology and applications in pain management. Study Design: Narrative review. Methods: The Pubmed NCBI and EMBASE databases was utilized to review published reports of clinical studies reported from 2000 to 2015, and ClinicalTrials.gov (www. clinicaltrials.gov/ct2/search) search function was used to document ongoing clinical trials [keywords: “chronic pain,” “disc pain,” “cell therapy,” “osteoarthritis,” “neuropathic,” “stem cell”] currently active and recruiting patients. Results: Articles were screened by title, abstract, and full article review. They were then analyzed by specific clinical indications and appropriate data were presented based on critical analysis of those articles. Limitations: More studies looking at the systematic use of stem cells in pain management will be required to draw conclusions about the benefits of the technology. Conclusion: Though the data from existing studies look promising for the use of stem cells as a novel therapeutic strategy for discogenic pain, neuropathic pain, and osteoarthritis, additional clinical studies will be needed to validate the benefit of the technology for clinical use. However, we hope that this narrative review will help guide pain physicians in making informed decisions for their patients about the potential of cell-based therapy for treating chronic pain conditions.",
keywords = "Chronic pain, Clinical trials, Disc pain, Mesenchymal stem cells, Neuropathic pain, Osteoarthritis, Pain management, Stem cell therapy",
author = "Krishnan Chakravarthy and Yian Chen and Cathy He and Paul Christo",
year = "2017",
month = "5",
day = "1",
language = "English (US)",
volume = "20",
pages = "293--305",
journal = "Pain Physician",
issn = "1533-3159",
publisher = "Association of Pain Management Anesthesiologists",
number = "4",

}

TY - JOUR

T1 - Stem cell therapy for chronic pain management

T2 - Review of uses, advances, and adverse effects

AU - Chakravarthy, Krishnan

AU - Chen, Yian

AU - He, Cathy

AU - Christo, Paul

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Background: This review article outlines the recent advances, uses, and adverse effects of cell-based therapy for chronic pain management. Cell based therapies are gaining increasing ground as novel treatment modalities for a variety of pain pathologies that include, but are not limited to, neuropathic pain and degenerative disc disease. As these treatment modalities become more common practice, we have focused our review to provide pain practitioners and other practicing physicians an understanding of the technology and to summarize key clinical data and existing clinical trials that are being pursued by clinical investigators worldwide. Objective: Review of stem cell technology and applications in pain management. Study Design: Narrative review. Methods: The Pubmed NCBI and EMBASE databases was utilized to review published reports of clinical studies reported from 2000 to 2015, and ClinicalTrials.gov (www. clinicaltrials.gov/ct2/search) search function was used to document ongoing clinical trials [keywords: “chronic pain,” “disc pain,” “cell therapy,” “osteoarthritis,” “neuropathic,” “stem cell”] currently active and recruiting patients. Results: Articles were screened by title, abstract, and full article review. They were then analyzed by specific clinical indications and appropriate data were presented based on critical analysis of those articles. Limitations: More studies looking at the systematic use of stem cells in pain management will be required to draw conclusions about the benefits of the technology. Conclusion: Though the data from existing studies look promising for the use of stem cells as a novel therapeutic strategy for discogenic pain, neuropathic pain, and osteoarthritis, additional clinical studies will be needed to validate the benefit of the technology for clinical use. However, we hope that this narrative review will help guide pain physicians in making informed decisions for their patients about the potential of cell-based therapy for treating chronic pain conditions.

AB - Background: This review article outlines the recent advances, uses, and adverse effects of cell-based therapy for chronic pain management. Cell based therapies are gaining increasing ground as novel treatment modalities for a variety of pain pathologies that include, but are not limited to, neuropathic pain and degenerative disc disease. As these treatment modalities become more common practice, we have focused our review to provide pain practitioners and other practicing physicians an understanding of the technology and to summarize key clinical data and existing clinical trials that are being pursued by clinical investigators worldwide. Objective: Review of stem cell technology and applications in pain management. Study Design: Narrative review. Methods: The Pubmed NCBI and EMBASE databases was utilized to review published reports of clinical studies reported from 2000 to 2015, and ClinicalTrials.gov (www. clinicaltrials.gov/ct2/search) search function was used to document ongoing clinical trials [keywords: “chronic pain,” “disc pain,” “cell therapy,” “osteoarthritis,” “neuropathic,” “stem cell”] currently active and recruiting patients. Results: Articles were screened by title, abstract, and full article review. They were then analyzed by specific clinical indications and appropriate data were presented based on critical analysis of those articles. Limitations: More studies looking at the systematic use of stem cells in pain management will be required to draw conclusions about the benefits of the technology. Conclusion: Though the data from existing studies look promising for the use of stem cells as a novel therapeutic strategy for discogenic pain, neuropathic pain, and osteoarthritis, additional clinical studies will be needed to validate the benefit of the technology for clinical use. However, we hope that this narrative review will help guide pain physicians in making informed decisions for their patients about the potential of cell-based therapy for treating chronic pain conditions.

KW - Chronic pain

KW - Clinical trials

KW - Disc pain

KW - Mesenchymal stem cells

KW - Neuropathic pain

KW - Osteoarthritis

KW - Pain management

KW - Stem cell therapy

UR - http://www.scopus.com/inward/record.url?scp=85019652611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019652611&partnerID=8YFLogxK

M3 - Review article

VL - 20

SP - 293

EP - 305

JO - Pain Physician

JF - Pain Physician

SN - 1533-3159

IS - 4

ER -